An open-label review was performed in 2016 in britain to analyze the feasibility, safety and efficacy of psilocybin in managing individuals with unipolar treatment-resistant depression with promising effects; Even though the research was modest and included only twelve patients, seven of those people achieved formal criteria for remission one week https://psilocybin-for-sale-onlin69596.madmouseblog.com/13803507/everything-about-psilocybin-vs-lsd-effects-comparison